Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Amortization - GoodwillEBIATLong-Term Debt RepaymentsNon-Current ReceivablesPreferred Shares IssuedReceivables RefundsShares IssuedShares Outstanding
Ratios

Ascendis Pharma A (ASND) Long-Term Debt Repayments: 2023-2025

Historic Long-Term Debt Repayments for Ascendis Pharma A (ASND) over the last 2 years, with Sep 2025 value amounting to -$7.7 million.

  • Ascendis Pharma A's Long-Term Debt Repayments fell 148.75% to -$7.7 million in Q3 2025 from the same period last year, while for Sep 2025 it was -$20.3 million, marking a year-over-year decrease of 67.58%. This contributed to the annual value of -$12.3 million for FY2024, which is 9.53% down from last year.
  • As of Q3 2025, Ascendis Pharma A's Long-Term Debt Repayments stood at -$7.7 million, which was down 23.68% from -$6.2 million recorded in Q2 2025.
  • Over the past 5 years, Ascendis Pharma A's Long-Term Debt Repayments peaked at -$2.8 million during Q3 2023, and registered a low of -$7.7 million during Q3 2025.
  • Moreover, its 3-year median value for Long-Term Debt Repayments was -$3.1 million (2024), whereas its average is -$3.9 million.
  • Data for Ascendis Pharma A's Long-Term Debt Repayments shows a maximum YoY slumped of 148.75% (in 2025) over the last 5 years.
  • Over the past 3 years, Ascendis Pharma A's Long-Term Debt Repayments (Quarterly) stood at -$2.9 million in 2023, then fell by 7.02% to -$3.1 million in 2024, then crashed by 148.75% to -$7.7 million in 2025.
  • Its Long-Term Debt Repayments stands at -$7.7 million for Q3 2025, versus -$6.2 million for Q2 2025 and -$3.2 million for Q1 2025.